Search Results 1-10 of 17227 for GLP-1 injections

  1. Diabetes drugs and weight loss - Mayo Clinic

    GLP-1 agonists for type 2 diabetes are generally taken by a shot, also called an injection. Most are taken once a day or once a week. GLP-1 agonists include the ...

  2. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight ...

  3. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is ...

  4. Prescription weight-loss drugs - Mayo Clinic

    But taken as a daily shot, it can help people with one of these conditions lose weight. It can make them want to eat less and make them feel full sooner. And it ...

  5. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide injection is also used together with a reduced-calorie diet and proper ...

  6. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    ... GLP-1-based obesity medication semaglutide. No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr ...

  7. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor ...

  8. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are cornerstone therapies for type 2 diabetes, obesity and cardiovascular health.

  9. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Some of these medications are taken by mouth, while others must be taken as a shot. ... Incretin mimetic (GLP-1 receptor agonists) ... No one diabetes treatment is ...

  10. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is also used together with diet and exercise to help lose weight and keep the ...